# Pulmonx Corporation (LUNG)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/LUNG/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 20.59M | $ -13.65M | N/A | $ 56.29M | $ 45.76M |
| 2025 | $ 92.66M | $ -55.29M | $ -1.99M | $ 56.36M | $ 54.12M |
| 2024 | $ 88.07M | $ -59.27M | $ -14.78M | $ 56.47M | $ 85.81M |
| 2023 | $ 74.26M | $ -65.79M | $ -42.84M | $ 41.42M | $ 118.32M |
| 2022 | $ 59.95M | $ -65.82M | $ -55.14M | $ 24.40M | $ 154.01M |
| 2021 | $ 57.55M | $ -57.84M | $ -104.21M | $ 26.46M | $ 193.24M |
| 2020 | $ 41.70M | $ -41.06M | $ -22.85M | $ 27.22M | $ 226.13M |
| 2019 | $ 43.10M | $ -26.36M | $ -45.17M | $ 227.15M | $ -187.38M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 1.23 |
| Liabilities / Eq | 1.62 |
| Current Ratio | 4.91 |

## Other views

- [Metrics](https://sponda.capital/en/LUNG.md)
- [Charts](https://sponda.capital/en/LUNG/charts.md)
- [Compare](https://sponda.capital/en/LUNG/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.